Cyclophosphamide for ocular inflammatory diseases (Q33517496)

27 July 2017

title

Cyclophosphamide for ocular inflammatory diseases (English)

1 reference

27 July 2017

0 references

Ebenezer Daniel

0 references

Grace A Levy-Clarke

1 reference

27 July 2017

Robert B. Nussenblatt

object named as

Robert B Nussenblatt

1 reference

27 July 2017

Jennifer E Thorne

1 reference

27 July 2017

Douglas A Jabs

1 reference

27 July 2017

John H Kempen

1 reference

27 July 2017

Siddharth S Pujari

1 reference

27 July 2017

Craig W Newcomb

1 reference

27 July 2017

Sapna Gangaputra

1 reference

27 July 2017

Eric B Suhler

1 reference

27 July 2017

James T Rosenbaum

1 reference

27 July 2017

C Stephen Foster

1 reference

27 July 2017

publication date

6 December 2009

1 reference

27 July 2017

1 reference

27 July 2017

volume

117

1 reference

27 July 2017

1 reference

27 July 2017

page(s)

356-365

1 reference

Methotrexate for ocular inflammatory diseases

27 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Prophylactic antibiotic usage for Pneumocystis jirovecii pneumonia in patients with systemic lupus erythematosus on cyclophosphamide: a survey of US rheumatologists and the review of literature

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Extra-articular manifestations and complications of rheumatoid arthritis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Treatment of systemic lupus erythematosus in 2006.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Polyarteritis nodosa revisited

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Interventions for mucous membrane pemphigoid/cicatricial pemphigoid and epidermolysis bullosa acquisita: a systematic literature review

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Cost-effectiveness of prophylaxis against Pneumocystis carinii pneumonia in patients with Wegner's granulomatosis undergoing immunosuppressive therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Disease-modifying antirheumatic drugs. Using their clinical pharmacological effects as a guide to their selection

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Side-effects of intravenous cyclophosphamide pulse therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Role of cyclophosphamide and high dose steroid in ocular cicatricial pemphigoid

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Wegener's Granulomatosis: Prospective Clinical and Therapeutic Experience With 85 Patients for 21 Years

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Transplacental teratogenesis and mutagenesis in mouse fetuses treated with cyclophosphamide

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Complications of corticosteroid and immunosuppressive drugs

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Immunosuppressive drugs in immune and inflammatory ocular disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Diagnosis and management of systemic Wegener's granulomatosis presenting with anterior ocular inflammatory disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Treatment With Immunosuppressive and Disease Modifying Drugs During Pregnancy and Lactation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

The eighth Frederick H. Verhoeff Lecture. presented by saiichi mishima, MD Behçet's disease in Japan: ophthalmologic aspects

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Treatment of ocular mucous membrane pemphigoid with immunosuppressive drug therapy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

[New concepts for the therapy of systemic lupus erythematosus]

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Diagnostic and therapeutic management of Vogt-Koyanagi-Harada syndrome

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Risk of ovarian failure and pregnancy outcome in patients with lupus nephritis treated with intravenous cyclophosphamide pulse therapy.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

The use of ACTH and cortisone in ophthalmology.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Treatment of patients with Wegener's granulomatosis or ANCA-associated vasculitis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

The effect of treatment and its related side effects in patients with severe ocular cicatricial pemphigoid

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819575

Immunosuppressive Therapy for Ocular Mucous Membrane Pemphigoid

31 October 2018

1 reference

12 December 2020

Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide

1 reference

12 December 2020

Ocular involvement in Wegener's granulomatosis responding to intravenous cyclophosphamide

1 reference

12 December 2020

[Severe Moorens ulcer: efficacy of monthly cyclophosphamide intravenous pulse treatment]

1 reference

12 December 2020

Ocular manifestations of Wegener's granulomatosis. Analysis of nine cases

1 reference

12 December 2020

Pulse IV cyclophosphamide in ocular inflammatory disease: efficacy and short-term safety

1 reference

12 December 2020

Sterility and testicular atrophy related to cyclophosphamide therapy

1 reference

12 December 2020

Treatment of Behçet's disease with cyclophosphamide

1 reference

12 December 2020

Therapy of scleritis with cytotoxic agents

1 reference

12 December 2020

Ocular toxicity of antineoplastic agents

1 reference

12 December 2020

Immunosuppressive Therapy in Ocular Cicatricial Pemphigoid

1 reference

12 December 2020

Cicatricial pemphigoid

1 reference

12 December 2020

Malignancy following treatment of rheumatoid arthritis with cyclophosphamide

1 reference

12 December 2020

Wegener's granulomatosis

1 reference

12 December 2020

Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease

1 reference

12 December 2020

Ocular presentation of polyarteritis nodosa. Clinical course and management with steroid and cytotoxic therapy

1 reference

12 December 2020

Treatment of severe refractory uveitis with intravenous cyclophosphamide

1 reference

12 December 2020

Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis

1 reference

12 December 2020

Vogt-Koyanagi-Harada syndrome

1 reference

12 December 2020

Destructive corneal and scleral disease associated with rheumatoid arthritis. Medical and surgical management

1 reference

12 December 2020

[Diagnosis and therapy of Wegener's granulomatosis based on ocular changes]

1 reference

12 December 2020

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis

1 reference

12 December 2020

Risk of developing certain malignancies is related to duration of immunosuppressive drug exposure in patients with rheumatic diseases

1 reference

12 December 2020

[Nitrogen mustard therapy of uveitis of unknown etiology.]

1 reference

12 December 2020

[Microscopic polyangiitis]

1 reference

12 December 2020

10.1016/J.OPHTHA.2009.06.060

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference